On Friday, Quince Therapeutics Inc (NASDAQ: QNCX) opened higher 5.80% from the last session, before settling in for the closing price of $3.45. Price fluctuations for QNCX have ranged from $0.72 to $3.58 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.53%. Company’s average yearly earnings per share was noted 16.54% at the time writing. With a float of $48.06 million, this company’s outstanding shares have now reached $54.49 million.
Quince Therapeutics Inc (QNCX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Quince Therapeutics Inc is 13.69%, while institutional ownership is 20.78%.
Quince Therapeutics Inc (QNCX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.28 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.1) by -0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.83% during the next five years compared to 7.53% growth over the previous five years of trading.
Quince Therapeutics Inc (NASDAQ: QNCX) Trading Performance Indicators
Check out the current performance indicators for Quince Therapeutics Inc (QNCX). In the past quarter, the stock posted a quick ratio of 1.12. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.22, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Quince Therapeutics Inc (QNCX)
Looking closely at Quince Therapeutics Inc (NASDAQ: QNCX), its last 5-days average volume was 1.56 million, which is a jump from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 94.30%.
During the past 100 days, Quince Therapeutics Inc’s (QNCX) raw stochastic average was set at 96.51%, which indicates a significant increase from 96.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.29 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.86, while its 200-day Moving Average is $1.51. However, in the short run, Quince Therapeutics Inc’s stock first resistance to watch stands at $3.83. Second resistance stands at $4.00. The third major resistance level sits at $4.28. If the price goes on to break the first support level at $3.38, it is likely to go to the next support level at $3.10. Should the price break the second support level, the third support level stands at $2.93.
Quince Therapeutics Inc (NASDAQ: QNCX) Key Stats
There are currently 55,681K shares outstanding in the company with a market cap of 203.24 million. Presently, the company’s annual sales total 0 K according to its annual income of -56,830 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -13,440 K.
